Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

Press Release: Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology
Press Releases

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.

Read More »
11/12/2025
In the News
In The news

AI Tools Allow Startups to Drastically Reduce Their Initial Costs

Source: Indianapolis Business Journal
Artificial intelligence is reshaping the startup landscape by drastically cutting costs and reducing the need for large teams or early venture funding. Investors such as Boomerang Ventures’ Tejas Vijh are seeing early-stage companies raise smaller rounds, build faster, and operate leaner as AI transforms both startup creation and venture capital strategy.

Read More »
11/07/2025
In the News
In The news

SiteLabs Secures $2M Seed Led by Boomerang Ventures

Source: Business Insider
Boomerang Ventures has led an oversubscribed seed round totaling $2 million for SiteLabs, a health-tech startup turning independent pharmacies into community-based hubs for preventive diagnostics and clinical research recruitment. With $1 million committed by Boomerang Ventures and additional backing from strategic investors like Labcorp Venture Fund and SC Launch Inc., SiteLabs plans to scale its platform to fuse pharmacy-care, screening and trial-access under one roof.

Read More »
11/06/2025
In the News
In The news

SiteLabs Raises $2M Led by Boomerang Ventures

Source: AP News
Boomerang Ventures, a digital-health studio and fund, led a $2 million oversubscribed seed investment in SiteLabs—a startup transforming independent pharmacies into community hubs for preventive screening, clinical trial access and diagnostics. The round includes strategic backing from Labcorp Venture Fund and SC Launch, positioning SiteLabs to scale rapidly in underserved regions.

Read More »
11/06/2025
In the News
In The news

Boomerang Ventures Leads $2M Seed Round for SiteLabs

Source: Tech Point
“Independent pharmacies are an untapped infrastructure for improving healthcare access in America,” said Darren Schaupp, CEO of SiteLabs. “They know their communities, see patients regularly, and can close critical gaps in preventive care and research recruitment — if we give them the right tools and partnerships.” With its pioneering point-of-care platform, SiteLabs is enabling pharmacies to deliver diagnostic screenings, connect patients to clinical trials, and create new revenue streams while improving health outcomes. Led by Boomerang Ventures, SiteLabs just closed a $2 million seed round to transform neighborhood pharmacies into frontline hubs for preventive care and research participation.

Read More »
11/03/2025
In the News
In The news

Boomerang Ventures Invests $1M in SiteLabs Seed Round

Source: Indianapolis Business Journal
Boomerang Ventures has led a $2 million seed investment in SiteLabs, an Anderson, South Carolina–based startup helping independent pharmacies offer onsite diagnostic testing. Founded in 2020, SiteLabs provides a digital platform that supports screenings for diabetes, cholesterol, strep throat and more. Boomerang contributed $1 million to the round, joined by Labcorp Venture Fund and SC Launch Inc., the investment arm of the South Carolina Research Authority.

Read More »
10/31/2025
Press Release: Boomerang Ventures Leads $2M Seed Round for SiteLabs
Press Releases

Boomerang Ventures Leads Oversubscribed $2M Seed Round Investment in SiteLabs to Transform Independent Pharmacies into Frontline Hubs for Preventive Care and Research

Boomerang Ventures has led a $2 million Seed Round for SiteLabs, a health tech startup transforming independent pharmacies into neighborhood hubs for preventive care and clinical research. With $1 million invested by Boomerang and additional backing from Labcorp Venture Fund and SC Launch, the funding will accelerate SiteLabs’ platform expansion to empower pharmacies with diagnostic tools, trial recruitment capabilities, and integrations that improve access, equity, and outcomes in healthcare.

Read More »
10/29/2025
In the News
In The news

Santa Barbara City College Partners with Mentavi Health to Deliver Rapid, Clinically Validated ADHD Evaluations for Students

Source: Morningstar
Santa Barbara City College (SBCC) has partnered with Mentavi Health to provide rapid, clinically validated ADHD evaluations for students. Through Mentavi’s asynchronous online diagnostic process, SBCC can deliver professional assessments within days instead of weeks, helping students access federally mandated accommodations faster.

Read More »
10/29/2025
In the News
In The news

How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights

Source: Psychiatric Times
Quintessence Psychiatry enhances ADHD assessments through Mentavi Health’s Diagnostic Evaluation, providing clinicians with data-driven insights and patients with clarity and compassion. Dr. Nona Kocher discusses how structured tools and open dialogue improve diagnostic accuracy, reduce stigma, and foster better patient engagement in treatment.

Read More »
10/16/2025
In the News
In The news

Asynchronous ADHD Assessment: New Tools for Better Evaluation

Source: Psychiatric Times
Telepsychiatry is evolving with tools like the Mentavi Diagnostic Evaluation—an asynchronous, clinically validated ADHD assessment for adults. This innovative platform improves diagnostic accuracy, reduces wait times, and enhances patient engagement while helping clinicians make more informed treatment decisions.

Read More »
10/13/2025

Back to News Page

Boomerang Ventures
Loading...